Venture Capital: Rapport Therapeutics Raises $150 Million For Precision Neuromedicines

August 24, 2023 | News, Venture Capital

“Rapport is pursuing a unique approach that exploits novel molecular insights with the goal of targeting ion channel receptors with unprecedented precision,” the company said.

Rapport Therapeutics, a clinical-stage biotechnology company focused on precision neuromedicines, has successfully raised $150 million in a Series B funding round. The funding will support ongoing clinical programs targeting seizure and psychiatric disorders, as well as the advancement of their precision neuromedicine discovery platform. The investment was led by Cormorant Asset Management and included participation from various notable investors including Fidelity Management & Research Company, Goldman Sachs Asset Management, Logos Capital, Perceptive Advisors, Sofinnova Investments, Surveyor Capital (a Citadel company), and funds and accounts advised by T. Rowe Price Associates, Inc.

As part of the funding round, Rapport has also appointed two new members to its Board of Directors: Dr. Raymond Kelleher from Cormorant Asset Management and Dr. James Healy from Sofinnova Investments.

Rapport’s approach involves leveraging receptor-associated proteins (RAPs) to precisely target receptors in specific regions of the nervous system implicated in neurological disorders. This approach is distinct from current treatments that target more broadly expressed receptors. The company aims to improve treatment efficacy and minimize side effects through this precision approach.

The company’s first program, focused on treating drug-resistant seizure disorders, is currently in Phase 1 clinical studies. Rapport is striving to bring about advancements in precision neuromedicine to offer better treatment options for neurological diseases while addressing issues like reduced efficacy and side effects associated with existing treatments.

Related Story: Elon Musk’s Neuralink Raises $280M Round Led By Founders Fund

Photo by Milad Fakurian on Unsplash

Free Industry News

Subscribe to our free newsletter for updates and news about alternatives investments.

  • This field is for validation purposes and should be left unchanged.


Latest Alternative Investment News
Digital Assets: Epic Lays Off 830 Employees As Metaverse Underperforms
September 29, 2023     Digital Assets, News

Earlier today, Tim Sweeney, the head of Epic Games, shared an email with the company’s employees, announcing some significant changes within the organization. In this message, Sweeney discussed the necessity…
Artificial Intelligence: Mysterious US-Based Books3 Dataset Used To Train AI Was A Massive Trove Of Pirated Books
September 29, 2023     Artificial Intelligence, Latest News, News

Thousands of books penned by some of Australia’s most esteemed authors may have fallen victim to what Booker prize-winning novelist Richard Flanagan has described as “the biggest act of copyright…銅鑼灣_Causeway_Bay_銅鑼灣時代廣場_Times_Square_office_Tower_One_阿里巴巴_Alibaba_Hong_Kong_June_2022_Px3_03.jpg
FinTech: Ant’s Chongqing Consumer Finance Arm Raising $616M To Ramp Up Loans
September 29, 2023     FinTech, News

Chongqing Consumer Finance, the consumer finance arm of Ant Group, a prominent player in China’s financial technology landscape, is currently in the process of raising a substantial sum of fresh…
Venture Capital: Mercury’s Fund V Mops Up $160M For US Startups “Between The Coasts”
September 29, 2023     News, Venture Capital

Mercury Fund, the premier early-stage venture firm with a focus on non-coastal tech hubs, has successfully closed its largest fund to date, Mercury Fund V, with a total capital commitment…